Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966829 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Progesterone Receptor (PGR) (AA 730-871) antibody
- Antibody type
- Monoclonal
- Description
- Ascitic fluid
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 730-871
- Isotype
- IgG
- Antibody clone number
- 8A11H1
- Vial size
- 0.1 mL
- Storage
- 4°C
Submitted references Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells.
Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B.
[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].
Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, Ishikawa H, Xue Q, Reierstad S, Innes J, Thung S, Kim JJ, Xu E, Bulun SE
The Journal of clinical endocrinology and metabolism 2007 Nov;92(11):4459-66
The Journal of clinical endocrinology and metabolism 2007 Nov;92(11):4459-66
Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
Buser AC, Gass-Handel EK, Wyszomierski SL, Doppler W, Leonhardt SA, Schaack J, Rosen JM, Watkin H, Anderson SM, Edwards DP
Molecular endocrinology (Baltimore, Md.) 2007 Jan;21(1):106-25
Molecular endocrinology (Baltimore, Md.) 2007 Jan;21(1):106-25
Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B.
Tung L, Abdel-Hafiz H, Shen T, Harvell DM, Nitao LK, Richer JK, Sartorius CA, Takimoto GS, Horwitz KB
Molecular endocrinology (Baltimore, Md.) 2006 Nov;20(11):2656-70
Molecular endocrinology (Baltimore, Md.) 2006 Nov;20(11):2656-70
[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].
Polo R, José Galindo M, Martínez E, Alvarez J, Arévalo JM, Asensi V, Cánoves D, Cáncer E, Collazos J, Estrada V, Gómez-Candela C, Johnston S, Locutura J, López-Aldeguer J, Lozano F, Miralles C, Muñoz-Sanz A, Ortega E, Pascua J, Pedrol E, Pulido F, San Martín M, Sanz J, Viciana P, Chamorro L, Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS)
Enfermedades infecciosas y microbiologia clinica 2006 Feb;24(2):96-117
Enfermedades infecciosas y microbiologia clinica 2006 Feb;24(2):96-117
No comments: Submit comment
No validations: Submit validation data